The Government on Friday said it has ordered the Drug Controller General of India (DCGI) to check the quality of drugs produced by Ranbaxy laboratories and to check if the firm is following standard manufacturing norms at its various manufacturing plants.
“The DCGI has already been ordered to review the good manufacturing practices compliance of the manufacturing facilities of Ranbaxy in India as well as to ascertain the quality, safety and efficacy of drugs manufactured for the domestic market at these facilities,” Minister of State of Chemicals and Fertilisers Srikant Kumar Jena said in a written reply in Rajya Sabha.